Clinical Trials Directory

Trials / Completed

CompletedNCT05242406

Effect of EMST Systemic Inflammation and Oxidative Stress in Patients With Moderate OSAS

Investigation of the Effect of Expiratory Muscle Strength Training Applied at Different Intensities on Systemic Inflammation and Oxidative Stress in Patients With Moderate Obstructive Sleep Apnea Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital · Academic / Other
Sex
Male
Age
19 Years – 60 Years
Healthy volunteers
Not accepted

Summary

It was aimed to investigate the effect of expiratory muscle strength training (EMST) applied at different intensities on systemic inflammation and oxidative stress in patients with moderate obstructive sleep apnea syndrome (OSAS). In the study, 32 male patients diagnosed with moderate OSAS will be included in the study. Participants will then be divided into 2 groups by block randomization. In the three-blind planned study; the first group will receive high-intensity %60 maximum expiratory pressure (MEP) EMST training, and the second group will be given low-intensity 30% of MEP, EMST training for 12 weeks. Disease-related symptoms, disease severity apnea-hypopnea index (AHI), oxidative stress index (OSI) and systemic inflammation level, exercise capacity, respiratory muscle strength, sleep quality, daytime sleepiness, and fatigue severity will be evaluated before and after the study.

Detailed description

Primary outcome measures are; disease severity, oxidative stress index and systemic inflammation. Secondary outcome measurements are; disease-related symptoms, exercise capacity, respiratory muscle strength, sleep quality, daytime sleepiness, and severity of fatigue.

Conditions

Interventions

TypeNameDescription
OTHERExpiratory muscle trainigThis exercise will be used to strengthen forced expiratory muscles.

Timeline

Start date
2022-06-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2022-02-16
Last updated
2023-08-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05242406. Inclusion in this directory is not an endorsement.